UNSPSC 85731835: Supplement bladder with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement bladder with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0TUB4KZ

UNSPSC 85731835 Supplement bladder with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows minimal alignment with state and local government procurement activity. The recent opportunities posted under this code do not reflect the clinical procedure the code nominally describes; instead, the records capture healthcare administration, pharmacy management, virtual care delivery, peer support services, and fire department medical direction. None of these activities involve urological surgical procedures or implantable medical devices. The mismatch suggests the code is either misapplied in state and local procurement systems or reflects a data classification error rather than genuine demand for the specific intervention named in the code.

The geographic spread of recent opportunities includes Georgia (Muscogee County), Florida (Collier County and Monroe County), California (San Mateo County and Santa Monica), posted between February and April 2026. County commissioners, health departments, and fire departments are the primary issuing bodies. Representative solicitations include Columbus Consolidated Government's RFP No. 26-0008 for inmate medical and pharmacy services due May 15, 2026; Collier County's RFP 25-8414 for pharmacy benefit management services due April 9, 2026; and Monroe County's RFP for virtual primary and urgent care services due April 16, 2026. None of these opportunities procure the bladder-augmentation procedure this code nominally describes, making the code unsuitable for business development targeting genuine state and local demand for urological implant services or related surgical care.